We speculated that some unknown mutations in KIT/PDGFRA or other genes, which failed to be detected by traditional PCR-based Sanger sequencing, may also take part in the development and therapeutic response of GIST. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.